Breaking News Today

$41.7 million boost to commercialise lifesaving medical discoveries

Published: (Updated: ) in Australian News by .

An innovative nasal treatment to fight COVID-19, common colds and flu is being taken to the next stage of testing, thanks to the Morrison Government’s $500 million Biomedical Translation Fund. Developed by Australian biotech company Ena Respiratory, INNA-051 works by stimulating the innate immune system, the first line of defence against the invasion of pathogens … Continue reading “$41.7 million boost to commercialise lifesaving medical discoveries”

An innovative nasal treatment to fight COVID-19, common colds and flu is being taken to the next stage of testing, thanks to the Morrison Government’s $500 million Biomedical Translation Fund.

Developed by Australian biotech company Ena Respiratory, INNA-051 works by stimulating the innate immune system, the first line of defence against the invasion of pathogens into the body.

The Government, alongside Brandon Capital Partners has committed $11.7 million to test the nasal spray treatment that targets the primary site of most respiratory virus infections, including SARS-CoV-2, the strain of coronavirus that causes COVID-19, and influenza.

The program has been designed so that if successful, INNA-051 will be manufactured and formulated in Australia, creating manufacturing jobs into the future.

In addition, four further projects will also share in almost $30 million dollars to commercialise their ideas. Each of these projects provide the potential to greatly improve the treatment for issues such as respiratory diseases, chronic pain and autoimmune diseases.

Minister for Health Greg Hunt said successful outcomes of the projects will improve the lives of Australians and potentially millions of people around the world.

“Australia’s health and medical researchers are world class and this investment will continue the proud Australian tradition of discovery and translation that saves lives and improves lives,” Minister Hunt said.

“The Morrison Government is backing Australia’s next generation of medical advances and this investment means these businesses have the potential to take their technology to the next level.”

Minister for Industry, Science and Technology Karen Andrews said this funding underpins the Morrison Government’s determination to deliver better health outcomes, while also encouraging economic growth and creating jobs.

READ:  Assad regime, allies slapped with US sanctions; more to come

“The Biomedical Translation Fund fosters potential breakthroughs that will not only improve people’s lives, but also help Australian companies create more jobs and grow into new markets,” Minister Andrews said.

“The Morrison Government is looking to develop our manufacturing capacity in medical products and this fund is yet another way we can help commercialise great Australian ideas right here at home.”

Funding consists of equal parts Commonwealth and private sector funding and is operated by three private sector fund managers: Brandon Capital Partners, OneVentures Healthcare Fund and BioScience Managers.

The other four investments made through the Fund are:

READ:  The 'I Alone Can Fix It' President Asks America For A Do-Over

The Morrison Government continues to invest in the cutting-edge medical technologies and treatments that will save lives, while growing a sector that can create jobs for Australians now and into the future.

Source: 16 News http://www.16news.com.au/index.php/2020/11/22/41-7-million-boost-to-commercialise-lifesaving-medical-discoveries/

Shares
Share This
Finance Advice 2021